Coronary Artery Disease
Conditions
Keywords
coronary artery bypass grafting, saphenous vein, coronary angiography
Brief summary
Left internal thoracic artery (LITA) has been acknowledged as the first graft of choice for coronary artery bypass grafting (CABG). However, it is still not conclusive which one is the best second graft of choice among right internal thoracic artery, radial artery, right gastroepiploic artery, saphenous vein, and etc., as well as its configuration for CABG. In our institution, saphenous vein has been primarily used for the second graft and we have harvested it with 'No touch technique'. We have been demonstrated the excellent long-term patency of this 'No touch saphenous vein' in many studies. However, it is still unknown which configuration is the better strategy for the saphenous vein as a Y-composite graft based on the left internal thoracic artery versus an aortocoronary conduit. Thus, we aimed to evaluate morphologic change of saphenous vein graft by 1-year intravascular ultrasound (IVUS) study and angiographic patency results between Y-composite graft and aortocoronary conduit.
Detailed description
The enrolled patient underwent routine sternotomy, and left internal thoracic artery (LITA) and saphenous vein (SV) are harvested. After harvest, the patient is randomized to Y-composite group or aortocoronary group. For Y-composite group, SV is anastomosed to LITA as Y-composite fashion. Then, LITA is anastomosed to left anterior descending artery. SV is anastomosed to the rest of the target vessels with sequential anastomosis technique (e.g. diagonal branch, obtuse marginal branch, posterolateral branch and posterior descending artery). For aortocoronary group, LITA is anastomosed to left anterior descending artery. Then, SV is anastomosed to ascending aorta using proximal anastomosis assist device without clamping the aorta. SV is anastomosed to the rest of the target vessels with sequential anastomosis technique (e.g. diagonal branch, obtuse marginal branch, posterolateral branch and posteriori descending artery). At 1-year follow-up, coronary angiography is performed to evaluate the patency of the saphenous vein graft. Clinical outcomes are also evaluated.
Interventions
PROCEDUREY-composite grafting
Saphenous vein is used as a Y-composite graft during coronary artery bypass grafting
PROCEDUREAortocoronary grafting
Saphenous vein is used as an aortocoronary graft during coronary artery bypass grafting
Sponsors
Ho Young Hwang
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Intervention model description
Saphenous vein as Y-composite graft based on the left internal thoracic artery versus aortocoronary conduit
Eligibility
Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* A patient who is going to receive coronary artery bypass grafting * Older than 19 years * Coronary artery bypass grafting is going to be performed with left internal thoracic artery and saphenous vein graft
Exclusion criteria
* Other concomitant procedures (e.g. valve or aorta surgery) is planned * Patients with severe comorbidities which limit the life expectancy of them below 1 year (e.g. terminal cancer) * Patients whose left internal thoracic artery or saphenous vein is not available due to the low quality, severe injury, or absence of the graft * Patients whose ascending aorta is not suitable to aortocoronary anastomosis (e.g. ascending aorta aneurysm, porcelain aorta) * Emergency operation * Patients who have connective tissue disease * Reoperative coronary artery bypass grafting
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Graft patency | at postoperative 1 year | Graft patency measured by coronary angiography |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| All-cause mortality | at postoperative 1 year | all deaths from any cause |
| Cardiac death | at postoperative 1 year | Any death related to cardiac events, including sudden death during follow-up |
| Target vessel revascularization | at postoperative 1 year | Intervention performed for the previously bypassed target vessel during follow-up |
| Reintervention | at postoperative 1 year | Any coronary intervention performed during follow-up due to the coronary artery disease |
| Major Adverse Cardiac Events (MACEs) | at postoperative 1 year | acute myocardial infarction, coronary reintervention, and cardiac death including sudden death during follow-up |
Countries
South Korea
Contacts
CONTACTHo Young Hwang, MD, PhD
CONTACTSuk Ho Sohn, MD
PRINCIPAL_INVESTIGATORHo Young Hwang, MD, PhD
Seoul National University Hospital
Outcome results
None listed